Cognitive Intervention to Improve Memory in Heart Failure Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

276 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-22

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive Intervention to Improve Memory in Heart Failure patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure

NCT05601817

Heart Failure Mild Cognitive Impairment

RECRUITING NA

COgnitive Intervention to Restore Attention Using Nature Environment

NCT04485507

Heart Failure Cognitive Dysfunction

COMPLETED NA

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment

NCT03205709

Mild Cognitive Impairment Memory Disorders Memory Impairment +3 more

COMPLETED NA

Cognitive Intervention to Improve Working Memory

NCT03687008

Single Ventricle Heart Disease

COMPLETED NA

Cognitive Function in Adults With Cardiac Disease

NCT01043315

Cognitive Impairment Cardiac Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A three arm randomized controlled trial of 276 heart failure patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure NYHA Class II Heart Failure NYHA Class III Heart Failure NYHA Class I

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Computerized Cognitive Training Brain HQ

Computerized cognitive training intervention using Brain HQ initiated and continued 1 hour/day, 5 days/week for 8 weeks

Group Type EXPERIMENTAL

Computerized Cognitive Training with Brain HQ

Intervention Type BEHAVIORAL

Computerized Cognitive Training Brain HQ activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Computerized Crossword Puzzles

General cognitive stimulation puzzles intervention initiated and continued 1 hour/day, 5 days/week for 8 weeks

Group Type ACTIVE_COMPARATOR

Computerized Crossword Puzzles

Intervention Type BEHAVIORAL

Computerized Crossword Puzzles activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Usual Care

No computerized cognitive intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computerized Cognitive Training with Brain HQ

Computerized Cognitive Training Brain HQ activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Intervention Type BEHAVIORAL

Computerized Crossword Puzzles

Computerized Crossword Puzzles activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 21 years of age
* Understands English
* Has access to a telephone
* Hears normal conversation
* For patients with hearing aids, able to wear and hear through headsets
* Diagnosis of chronic heart failure, stage C, NYHA I, II or III
* Receiving guideline derived medical therapy
* Heart failure validated by echocardiography or other method in past 2 years
* Able to read a computer screen with or without glasses or lenses

Exclusion Criteria

* History of drug or alcohol abuse or major psychiatric diagnosis present before the heart failure diagnosis
* Alzheimer or other dementia diagnosis or central nervous system degenerative disorder
* Terminal cancer
* Patients with baseline Montreal Cognitive Assessment (MoCA) score of less than 19

Supplement Eligibility: First 144 patients randomized in the parent trial.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No